New analysis indicates that individuals who stopped taking tirzepatide just after one calendar year regained about 14% in the weight they lost. The FDA authorized the drug for Older people with obesity or who are overweight with not less than just one weight-associated problem. professionals advise remaining careful about choosing to get copyrigh